CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 825 enrolled
Drug / intervention
Web-based decision aid plus personalized risk assessment +2 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00251862
NCT00251862N/ACompleted
CompareCT.gov

Shared Decision-Making for Colorectal Cancer Screening

Agency for Healthcare Research and Quality (AHRQ)·interventional·Posted Nov 11, 2005·Updated Dec 27, 2013

In Brief

A clinical study evaluating Web-based decision aid plus personalized risk assessment, Web-based decision aid alone, and 1 other intervention for Colorectal Cancer. Completed, enrolled 825 participants across 2 sites.

Detailed Summary

The overall objective of this study is to conduct a three-arm randomized controlled trial to evaluate the impact of an interactive, web-based decision aid on shared decision-making and patient adherence to colorectal cancer (CRC) screening recommendations.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColorectal Cancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 11, 2005
Enrollment StartJan 1, 2005
Primary CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 20.6 years ago

Interventions

Web-based decision aid plus personalized risk assessmentbehavioral

Patients review a computer-based decision aid that discuss the pros and cons of of 5 recommended CRC screening options and provides personalized 10-year estimates of CRC risk prior to meeting with their provider to discuss CRC screening.

Web-based decision aid alonebehavioral

Patients review a computer-based decision aid that discuss the pros and cons of the 5 recommended CRC screening options prior to meeting with their provider to discuss CRC screening.

Generic websitebehavioral

Patients review a generic website that discuss ways to reduce overall cancer risk.